Papiez, L.
The University of Texas at Dallas,
United States
2024 Rank: 218518
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2089 out of 116246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 218518 | 218420 |
| Total Cites | 6832 | 7486 |
| H-index | 27 | 28 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 99 | 123 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 411 | 518 |
| Number of Single+First+Last Authored Papers | 69 | 69 |
| Total Cites to Single+First+Last Authored Papers | 830 | 993 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5058 | 5334 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.40 |
| Self-Citation Percentage |
8.74%
|
|
Papiez, L.
The University of Texas at Dallas,
United States
2023 Rank: 214641
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2097 out of 109758 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 214641 | 212048 |
| Total Cites | 6364 | 6993 |
| H-index | 26 | 27 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 98 | 122 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 395 | 501 |
| Number of Single+First+Last Authored Papers | 69 | 69 |
| Total Cites to Single+First+Last Authored Papers | 792 | 951 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4669 | 4933 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.42 |
| Self-Citation Percentage |
8.99%
|
|
Papiez, L.
The University of Texas at Dallas,
United States
2022 Rank: 208205
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2061 out of 105572 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 208205 | 203821 |
| Total Cites | 5772 | 6367 |
| H-index | 25 | 26 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 97 | 121 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 371 | 475 |
| Number of Single+First+Last Authored Papers | 70 | 70 |
| Total Cites to Single+First+Last Authored Papers | 745 | 901 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4183 | 4427 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.44 |
| Self-Citation Percentage |
9.35%
|
|
Papiez, L.
The University of Texas at Dallas,
United States
2021 Rank: 200227
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1991 out of 101860 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 200227 | 197471 |
| Total Cites | 5545 | 6132 |
| H-index | 25 | 26 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 96 | 120 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 362 | 465 |
| Number of Single+First+Last Authored Papers | 70 | 70 |
| Total Cites to Single+First+Last Authored Papers | 720 | 874 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4000 | 4239 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.45 |
| Self-Citation Percentage |
9.57%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.